TuisOCEAW • NASDAQ
add
Ocean Biomedical
Vorige sluiting
$0,040
Dagwisseling
$0,036 - $0,039
Jaarwisseling
$0,019 - $0,68
Markkapitalisasie
35,00 m USD
Gemiddelde volume
41,92 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2023info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 2,66 m | -16,33% |
Netto inkomste | -14,09 m | -284,05% |
Netto winsgrens | — | — |
Wins per aandeel | -0,52 | — |
EBITDA | — | — |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2023info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 31,00 k | -73,28% |
Totale bates | 1,03 m | -9,08% |
Totale aanspreeklikheid | 76,26 m | 595,12% |
Totale ekwiteit | -75,22 m | — |
Uitstaande aandele | 34,65 m | — |
Prys om te bespreek | -0,02 | — |
Opbrengs op bates | -415,88% | — |
Opbrengs op kapitaal | 12,88% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2023info | J/J-verandering |
|---|---|---|
Netto inkomste | -14,09 m | -284,05% |
Kontant van bedrywe | -1,13 m | -155,66% |
Kontant van beleggings | — | — |
Kontant van finansiering | 0,00 | -100,00% |
Netto kontantverandering | -1,13 m | -303,57% |
Beskikbare kontantvloei | -833,50 k | — |
Meer oor
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Gestig
2019
Webwerf
Werknemers
9
